Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changzhou AniKare Pharmatech is a biotechnology company and contract research organization (CRO) based in Changzhou, China, specializing in small molecule drug discovery and development. The company provides a comprehensive suite of services, including medicinal chemistry, lead optimization, custom synthesis, and process chemistry, to support global pharmaceutical and biotech partners. AniKare leverages its expertise in synthetic chemistry to accelerate the development of innovative therapeutics for both human and animal health sectors. The firm operates out of the West Taihu Lake Science and Technology Industrial Park, utilizing advanced laboratory facilities for its R&D activities. By combining contract services with internal research initiatives, AniKare aims to bridge the gap between early-stage discovery and clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changzhou AniKare Pharmatech.